United Biochemicals manufactures high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.
VWR president and CEO Manuel Brocke-Benz said, "United Biochemicals’ manufacturing expertise, combined with VWR’s existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."
Financial details of the transaction remain confidential.
United Biochemicals president Fayyaz Hussain said, "This acquisition will allow United Biochemicals to leverage VWR’s global sales and marketing organization to grow our business."